Inhibrx, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2019 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Inhibrx, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q1 2024.
- Inhibrx, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$4.89M, a 5.15% increase year-over-year.
- Inhibrx, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$20.2M, a 6.41% decline year-over-year.
- Inhibrx, Inc. annual Nonoperating Income (Expense) for 2023 was -$20.5M, a 27.3% decline from 2022.
- Inhibrx, Inc. annual Nonoperating Income (Expense) for 2022 was -$16.1M, a 210% decline from 2021.
- Inhibrx, Inc. annual Nonoperating Income (Expense) for 2021 was -$5.2M, a 36.5% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)